Seleznenko T. Effectiveness of medication Tecom in correction of hemostasis in lung diseases.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0499U000398

Thesis Registration Form

0499U000398.pdf

Applicant for

Specialization

  • 14.01.27 - Пульмонологія

18-01-1999

Specialized Academic Board

Д 26.552.01

State organization “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky National academy of medical sciences of Ukraine”

Essay

The influence of new medication Tecom being a combination of high concentrated omega-3 polyunsaturated fatty acids on the hemostasis parameters in lung diseases was investigated. The investigation was performed in experimental model of inflammation in lungs, in tests in vitro and in clinic. As a result it has been determined that Tecom has hypocoagulative and antiaggregative activity and may be recommended for complex treatment of patients with lung diseases with syndrome of hypercoagulation of blood.

Read more

Similar theses

0421U103753

Cherednichenko Nataliia A.

Features of conducting and predicting the effectiveness of treatment of patients with bronchial asthma taking into account the polymorphism of the leukotriene gene C4-synthetase

0421U102959

Kanarskyi Oleksandr A.

Antioxidant therapy effectiveness in the functional state of the cardiorespiratory system correction in patients with bronchial asthma

0521U101245

Kuryk Lesia M.

Mechanisms of adaptive capacity formation and approaches to the correction of their disorders in patients with bronchial asthma

0421U101298

Kravtsova Oksana M.

Control of treatment of bronchial asthma with different phenotypes in children

0421U100418

Makarova Galyna V.

The effectiveness of endobronchial nitrogen monoxide (NO) administration in the complex treatment of patients with exacerbation of chronic bronchitis